ZYTRAM XL 150 MG
TRAMADOL HYDROCHLORIDE : 150 MG · DIN 02286424 · PURDUE PHARMA
Health Canada status: MARKETED
What is ZYTRAM XL?
ZYTRAM XL 150 MG contains TRAMADOL HYDROCHLORIDE : 150 MG. It is listed in the Health Canada Drug Product Database under DIN 02286424, held by PURDUE PHARMA, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 07-Dec-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ZYTRAM XL used for?
ZYTRAM XL (tramadol hydrochloride controlled release tablets) is indicated for: • the management of moderate to moderately severe pain in adults who require continuous treatment for several days or more.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02286424 |
|---|---|
| Brand name | ZYTRAM XL |
| Generic / active ingredient | TRAMADOL HYDROCHLORIDE : 150 MG |
| Manufacturer | PURDUE PHARMA |
| Strength | 150 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AX02 TRAMADOL |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 07-Dec-2006 |
How is it stored and handled?
ZYTRAM XL should be stored securely to avoid theft or misuse.
How is it supplied?
Opaque plastic bottles of 60 tablets.
What can be used instead?
Other Canadian products sharing ATC code N02AX02 TRAMADOL. 22 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-TRAMADOL | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 02426153 |
| AURO-TRAMADOL | 50 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02479672 |
| DURELA | 100 MG | CAPSULE (EXTENDED RELEASE) | CIPHER PHARMACEUTICALS INC | MARKETED | DIN 02373017 |
| DURELA | 200 MG | CAPSULE (EXTENDED RELEASE) | CIPHER PHARMACEUTICALS INC | MARKETED | DIN 02373025 |
| DURELA | 300 MG | CAPSULE (EXTENDED RELEASE) | CIPHER PHARMACEUTICALS INC | MARKETED | DIN 02373033 |
| JAMP TRAMADOL HCL | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02518759 |
| MAR-TRAMADOL | 50 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02480859 |
| RALIVIA | 100 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02299194 |
| RALIVIA | 200 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02299208 |
| RALIVIA | 300 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02299216 |
Who else supplies TRAMADOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRAMADOL appears in 695 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.